Tudor Investment Corp’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,553
| Closed | -$938K | – | 1485 |
|
|
2024
Q4 | $938K | Buy |
+28,553
| New | +$938K | ﹤0.01% | 1029 |
|
|
2024
Q2 | – | Sell |
-35,734
| Closed | -$1.04M | – | 1467 |
|
|
2024
Q1 | $1.04M | Buy |
35,734
+7,836
| +28% | +$229K | 0.01% | 870 |
|
|
2023
Q4 | $621K | Buy |
+27,898
| New | +$621K | 0.01% | 1075 |
|
|
2023
Q2 | – | Sell |
-14,755
| Closed | -$339K | – | 1494 |
|
|
2023
Q1 | $339K | Sell |
14,755
-10,810
| -42% | -$248K | 0.01% | 1242 |
|
|
2022
Q4 | $718K | Buy |
25,565
+3,221
| +14% | +$90.5K | 0.01% | 992 |
|
|
2022
Q3 | $632K | Sell |
22,344
-384
| -2% | -$10.9K | 0.01% | 1016 |
|
|
2022
Q2 | $504K | Sell |
22,728
-56,607
| -71% | -$1.26M | 0.01% | 1075 |
|
|
2022
Q1 | $2.31M | Sell |
79,335
-4,480
| -5% | -$130K | 0.05% | 465 |
|
|
2021
Q4 | $2.76M | Buy |
+83,815
| New | +$2.76M | 0.05% | 463 |
|
|
2021
Q2 | – | Sell |
-7,690
| Closed | -$397K | – | 1455 |
|
|
2021
Q1 | $397K | Sell |
7,690
-17,277
| -69% | -$892K | 0.01% | 1201 |
|
|
2020
Q4 | $1.08M | Sell |
24,967
-31,371
| -56% | -$1.36M | 0.03% | 659 |
|
|
2020
Q3 | $1.97M | Buy |
56,338
+39,493
| +234% | +$1.38M | 0.09% | 306 |
|
|
2020
Q2 | $901K | Buy |
+16,845
| New | +$901K | 0.04% | 499 |
|
|
2019
Q4 | – | Sell |
-13,815
| Closed | -$448K | – | 1114 |
|
|
2019
Q3 | $448K | Buy |
13,815
+4,654
| +51% | +$151K | 0.02% | 734 |
|
|
2019
Q2 | $457K | Buy |
+9,161
| New | +$457K | 0.01% | 738 |
|
|
2015
Q3 | – | Sell |
-1,900
| Closed | -$211K | – | 1447 |
|
|
2015
Q2 | $211K | Buy |
+1,900
| New | +$211K | 0.01% | 1279 |
|
|
2015
Q1 | – | Sell |
-2,061
| Closed | -$231K | – | 1415 |
|
|
2014
Q4 | $231K | Buy |
+2,061
| New | +$231K | 0.01% | 1183 |
|